Search results for "Diabetes"
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes
An industry-funded study of patients ages 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
https://immattersacp.org/weekly/archives/2023/04/04/1.htm
4 Apr 2023
Temporary weight management programs may have long-term cardiometabolic benefits
Trial participants who completed behavioral weight management programs had long-term reductions in systolic blood pressure, cholesterol levels, and HbA1c level relative to comparators, but weight regain reduced these differences over time, a systematic review and meta-analysis found.
https://immattersacp.org/weekly/archives/2023/04/04/2.htm
4 Apr 2023
Uncover trauma to treat patients efficiently
Uncovering past trauma in a patient's life can help steer the physician toward treatment of current health problems.
https://immattersacp.org/archives/2023/04/uncover-trauma-to-treat-patients-efficiently.htm
1 Apr 2023
MKSAP Quiz: Motivating lifestyle change
A 28-year-old man is evaluated during a follow-up visit for hypertension and diabetes mellitus. He works two jobs and eats fast food for most meals. Which of the following is the most appropriate management?
https://immattersacp.org/weekly/archives/2023/03/21/3.htm
21 Mar 2023
Hydrochlorothiazide no better than placebo for preventing kidney stone recurrence
A randomized, double-blind, placebo-controlled trial in Switzerland found that patients with a history of recurring kidney stones were no less likely to experience symptomatic or radiologic recurrence with hydrochlorothiazide versus placebo.
https://immattersacp.org/weekly/archives/2023/03/07/1.htm
7 Mar 2023
Big barrier to buprenorphine removed
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://immattersacp.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023
Combo treatment approved for asthma
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/03/combo-treatment-approved-for-asthma.htm
1 Mar 2023
Getting to know GLP-1 receptor agonists
Choosing among glucagon-like peptide-1 (GLP-1) receptor agonists depends on many factors, such as the desired outcome and individual risks among patients.
https://immattersacp.org/archives/2023/03/getting-to-know-glp-1-receptor-agonists.htm
1 Mar 2023
‘Getting back to normal’ at Internal Medicine Meeting 2023
The meeting will be held April 27-29 in San Diego and virtually, with in-person precourses offered on April 25-26.
https://immattersacp.org/archives/2023/03/getting-back-to-normal-at-internal-medicine-meeting-2023.htm
1 Mar 2023